NO20072318L - Okular levering av polymere leveringsformuleringer - Google Patents
Okular levering av polymere leveringsformuleringerInfo
- Publication number
- NO20072318L NO20072318L NO20072318A NO20072318A NO20072318L NO 20072318 L NO20072318 L NO 20072318L NO 20072318 A NO20072318 A NO 20072318A NO 20072318 A NO20072318 A NO 20072318A NO 20072318 L NO20072318 L NO 20072318L
- Authority
- NO
- Norway
- Prior art keywords
- delivery
- composition
- mammal
- thermoplastic polymer
- polymeric
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 238000009472 formulation Methods 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 2
- 230000009969 flowable effect Effects 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 2
- 229920001169 thermoplastic Polymers 0.000 abstract 2
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 239000003124 biologic agent Substances 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000007943 implant Substances 0.000 abstract 1
- 239000002207 metabolite Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61572704P | 2004-10-04 | 2004-10-04 | |
US62863004P | 2004-11-17 | 2004-11-17 | |
US62913304P | 2004-11-18 | 2004-11-18 | |
PCT/US2005/035865 WO2006041942A2 (fr) | 2004-10-04 | 2005-10-04 | Apport oculaire de preparations d'apport polymere |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20072318L true NO20072318L (no) | 2007-05-04 |
Family
ID=36148882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20072318A NO20072318L (no) | 2004-10-04 | 2007-05-04 | Okular levering av polymere leveringsformuleringer |
Country Status (10)
Country | Link |
---|---|
US (1) | US20060210604A1 (fr) |
EP (1) | EP1804751A2 (fr) |
JP (1) | JP2008520547A (fr) |
KR (1) | KR20070083941A (fr) |
AU (1) | AU2005294382A1 (fr) |
BR (1) | BRPI0516308A2 (fr) |
CA (1) | CA2582374A1 (fr) |
MX (1) | MX2007003789A (fr) |
NO (1) | NO20072318L (fr) |
WO (1) | WO2006041942A2 (fr) |
Families Citing this family (123)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7431710B2 (en) | 2002-04-08 | 2008-10-07 | Glaukos Corporation | Ocular implants with anchors and methods thereof |
US20080220049A1 (en) * | 2003-12-05 | 2008-09-11 | Adnexus, A Bristol-Myers Squibb R&D Company | Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins |
AU2004296376B2 (en) | 2003-12-05 | 2010-03-04 | Bristol-Myers Squibb Company | Inhibitors of type 2 vascular endothelial growth factor receptors |
US9498457B2 (en) | 2004-04-30 | 2016-11-22 | Allergan, Inc. | Hypotensive prostamide-containing biodegradable intraocular implants and related implants |
US7799336B2 (en) | 2004-04-30 | 2010-09-21 | Allergan, Inc. | Hypotensive lipid-containing biodegradable intraocular implants and related methods |
US7993634B2 (en) | 2004-04-30 | 2011-08-09 | Allergan, Inc. | Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods |
US8722097B2 (en) | 2004-04-30 | 2014-05-13 | Allergan, Inc. | Oil-in-water method for making polymeric implants containing a hypotensive lipid |
ES2432556T3 (es) | 2004-08-04 | 2013-12-04 | Evonik Corporation | Métodos para fabricar dispositivos de suministro y sus dispositivos |
US20080038316A1 (en) * | 2004-10-01 | 2008-02-14 | Wong Vernon G | Conveniently implantable sustained release drug compositions |
US8313763B2 (en) * | 2004-10-04 | 2012-11-20 | Tolmar Therapeutics, Inc. | Sustained delivery formulations of rapamycin compounds |
US8663639B2 (en) | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
BRPI0608152A2 (pt) | 2005-02-09 | 2009-11-10 | Macusight Inc | formulações para tratamento ocular |
US7803817B2 (en) * | 2005-05-11 | 2010-09-28 | Vecta, Ltd. | Composition and methods for inhibiting gastric acid secretion |
US7981908B2 (en) | 2005-05-11 | 2011-07-19 | Vecta, Ltd. | Compositions and methods for inhibiting gastric acid secretion |
US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
GB0523964D0 (en) * | 2005-11-24 | 2006-01-04 | Arakis Ltd | The treatment of ophthalmic diseases |
WO2007076358A1 (fr) * | 2005-12-23 | 2007-07-05 | Alcon, Inc. | Preparation pharmaceutique pour l'administration, dans l'oeil, de composes inhibiteurs des récepteurs tyrosine kinases (rtki) |
WO2007092620A2 (fr) | 2006-02-09 | 2007-08-16 | Macusight, Inc. | Formulations stables et leurs procedes de preparation et d'utilisation |
US20080261893A1 (en) * | 2006-02-24 | 2008-10-23 | Denise Barbut | Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing |
CA2645488C (fr) | 2006-03-23 | 2014-09-02 | Macusight, Inc. | Formulations comprenant de la rapamycine et methodes d'utilisation de celle-ci destinees aux maladies ou aux pathologies liees a la permeabilite vasculaire |
WO2007112272A2 (fr) | 2006-03-28 | 2007-10-04 | Javelin Pharmaceuticals, Inc. | Formulations de diclofénac et de cyclodextrine bêta à faible dosage |
CN101410012A (zh) * | 2006-03-28 | 2009-04-15 | 杰佛林制药公司 | 低剂量的非甾体抗炎药和β-环糊精的制剂 |
US20070260203A1 (en) * | 2006-05-04 | 2007-11-08 | Allergan, Inc. | Vasoactive agent intraocular implant |
WO2008015695A2 (fr) * | 2006-05-15 | 2008-02-07 | Sun Pharmaceutical Industries Limited | Complexe d'inclusion |
US20070275098A1 (en) * | 2006-05-19 | 2007-11-29 | T.R.P. Company, Inc, A Nevada Corporation | Formulation and methodology for the treatment for eye impairment symptoms |
DK2046334T3 (da) * | 2006-07-25 | 2014-08-25 | Vecta Ltd | Sammensætninger og fremgangsmåder til at hæmme mavesyresekretion ved at anvende derivater af små dicarboxylsyrer i kombination med PPI |
US8039010B2 (en) | 2006-11-03 | 2011-10-18 | Allergan, Inc. | Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier |
BRPI0719597A2 (pt) | 2006-11-22 | 2013-12-17 | Adnexus A Bristol Myers Squibb R & D Company | Produtos terapêuticos objetivados baseados em proteínas manipuladas para receptores de quinases de tirosina, incluindo igf-ir |
WO2008074153A1 (fr) | 2006-12-18 | 2008-06-26 | Electronic Dietary Foods Inc. | Dispositif d'administration d'une substance |
US8846073B2 (en) | 2006-12-19 | 2014-09-30 | Allergan, Inc. | Low temperature processes for making cyclic lipid implants for intraocular use |
US20080275030A1 (en) | 2007-01-19 | 2008-11-06 | Sveinbjorn Gizurarson | Methods and Compositions for the Delivery of a Therapeutic Agent |
FI3660073T3 (fi) | 2007-02-15 | 2023-09-11 | Tolmar International Ltd | Matalan purskeen poly(laktidi-ko-glykolidi) |
AU2008225100A1 (en) * | 2007-03-12 | 2008-09-18 | Mayo Foundation For Medical Education And Research | Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing |
US8092825B2 (en) * | 2007-03-29 | 2012-01-10 | The University Of Tennessee Research Foundation | Glycan binding proteins as therapeutic targets for retinal disorders and treatment methods based thereon |
CN101801415B (zh) | 2007-05-25 | 2015-09-23 | Rb医药品有限公司 | 利培酮化合物的持续递送制剂 |
JP5539875B2 (ja) | 2007-08-31 | 2014-07-02 | アルキメデス・デベロップメント・リミテッド | 非水性医薬組成物 |
EP2030610A1 (fr) * | 2007-08-31 | 2009-03-04 | Archimedes Development Limited | Compositions pharmaceutiques non aqueuses |
PE20091265A1 (es) * | 2007-12-13 | 2009-09-18 | Univ Kyushu Nat Univ Corp | Nanoparticulas que contienen pioglitazona |
US8728528B2 (en) | 2007-12-20 | 2014-05-20 | Evonik Corporation | Process for preparing microparticles having a low residual solvent volume |
US20090181068A1 (en) * | 2008-01-14 | 2009-07-16 | Dunn Richard L | Low Viscosity Liquid Polymeric Delivery System |
WO2009102421A2 (fr) | 2008-02-14 | 2009-08-20 | Bristol-Myers Squibb Company | Agents thérapeutiques cibles basés sur des protéines fabriquées qui se lient au récepteur de l’egf |
US20090263489A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedic, Inc. | Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation |
US9132119B2 (en) * | 2008-04-18 | 2015-09-15 | Medtronic, Inc. | Clonidine formulation in a polyorthoester carrier |
US8420114B2 (en) * | 2008-04-18 | 2013-04-16 | Warsaw Orthopedic, Inc. | Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation |
JP2011520961A (ja) | 2008-05-22 | 2011-07-21 | ブリストル−マイヤーズ スクイブ カンパニー | 多価フィブロネクチンをベースとする足場ドメインタンパク質 |
EP2344198B1 (fr) * | 2008-09-27 | 2020-11-04 | Jina Pharmaceuticals Inc. | Préparations pharmaceutiques à base de lipide(s) à usage topique |
US20100104654A1 (en) | 2008-10-27 | 2010-04-29 | Allergan, Inc. | Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof |
TWI496582B (zh) | 2008-11-24 | 2015-08-21 | 必治妥美雅史谷比公司 | 雙重專一性之egfr/igfir結合分子 |
US8822610B2 (en) | 2008-12-22 | 2014-09-02 | ATRP Solutions, Inc. | Control over controlled radical polymerization processes |
US8815971B2 (en) | 2008-12-22 | 2014-08-26 | ATRP Solutions, Inc. | Control over controlled radical polymerization processes |
US20100204325A1 (en) * | 2009-02-11 | 2010-08-12 | Allergan, Inc. | Valproic acid drug delivery systems and intraocular therapeutic uses thereof |
US9636255B2 (en) | 2009-02-13 | 2017-05-02 | Dose Medical Corporation | Uveoscleral drug delivery implant and methods for implanting the same |
WO2010123574A1 (fr) | 2009-04-23 | 2010-10-28 | Atrp Solutions Inc | Macromolécules en étoile pour soins d'hygiène personnelle et soins domestiques |
US9783628B2 (en) | 2009-04-23 | 2017-10-10 | ATRP Solutions, Inc. | Dual-mechanism thickening agents for hydraulic fracturing fluids |
US8173750B2 (en) | 2009-04-23 | 2012-05-08 | ATRP Solutions, Inc. | Star macromolecules for personal and home care |
US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
US8513259B2 (en) | 2009-07-03 | 2013-08-20 | Jdp Therapeutics, Inc. | Non-sedating antihistamine injection formulations and methods of use thereof |
US8263581B2 (en) | 2009-07-03 | 2012-09-11 | Jdp Therapeutics, Inc. | Non-sedating antihistamine injection formulations and methods of use thereof |
JP5641483B2 (ja) | 2009-08-18 | 2014-12-17 | 国立大学法人東北大学 | 持続性ドラッグデリバリーシステム |
US20110097380A1 (en) * | 2009-10-28 | 2011-04-28 | Warsaw Orthopedic, Inc. | Clonidine formulations having antimicrobial properties |
EP2509596B1 (fr) | 2009-12-08 | 2019-08-28 | Case Western Reserve University | Gamma acides aminés pour le traitement de troubles oculaires |
US10285936B2 (en) | 2010-05-31 | 2019-05-14 | Laboratorios Farmacéuticos Rovi, S.A. | Injectable composition with aromatase inhibitor |
US10350159B2 (en) | 2010-05-31 | 2019-07-16 | Laboratories Farmacéuticos Rovi, S.A. | Paliperidone implant formulation |
EP2394663B1 (fr) | 2010-05-31 | 2021-10-13 | Laboratorios Farmaceuticos Rovi, S.A. | Compositions pour implants biodégradables in situ injectables |
US10335366B2 (en) | 2010-05-31 | 2019-07-02 | Laboratorios Farmacéuticos Rovi, S.A. | Risperidone or paliperidone implant formulation |
US9562089B2 (en) | 2010-05-26 | 2017-02-07 | Bristol-Myers Squibb Company | Fibronectin based scaffold proteins having improved stability |
US10881605B2 (en) | 2010-05-31 | 2021-01-05 | Laboratorios Farmaceuticos Rovi, S.A. | Methods for the preparation of injectable depot compositions |
US10463607B2 (en) | 2010-05-31 | 2019-11-05 | Laboratorios Farmaceutics Rofi S.A. | Antipsychotic Injectable Depot Composition |
GB2481017B (en) | 2010-06-08 | 2015-01-07 | Rb Pharmaceuticals Ltd | Microparticle buprenorphine suspension |
US9272044B2 (en) | 2010-06-08 | 2016-03-01 | Indivior Uk Limited | Injectable flowable composition buprenorphine |
GB2481018B (en) * | 2010-06-08 | 2015-03-18 | Rb Pharmaceuticals Ltd | Injectable flowable composition comprising buprenorphine |
US9668915B2 (en) | 2010-11-24 | 2017-06-06 | Dose Medical Corporation | Drug eluting ocular implant |
WO2012070033A1 (fr) | 2010-11-26 | 2012-05-31 | University Of The Witwatersrand, Johannesburg | Implant pour la libération contrôlée d'agents pharmaceutiquement actifs |
US9018202B2 (en) | 2010-12-03 | 2015-04-28 | Allergan, Inc. | Methods for treating diseases of the retina |
US9587064B2 (en) | 2010-12-08 | 2017-03-07 | ATRP Solutions, Inc. | Salt-tolerant star macromolecules |
WO2012111029A2 (fr) * | 2011-02-18 | 2012-08-23 | M/S. Appasamy Associates | Composition ophtalmique pour la dilatation des pupilles |
PT2697257T (pt) | 2011-04-13 | 2016-12-28 | Bristol Myers Squibb Co | Proteínas de fusão fc compreendendo novos ligantes ou arranjos |
EP2709669A1 (fr) | 2011-05-17 | 2014-03-26 | Bristol-Myers Squibb Company | Procédés de maintien de la pegylation de polypeptides |
US10245178B1 (en) | 2011-06-07 | 2019-04-02 | Glaukos Corporation | Anterior chamber drug-eluting ocular implant |
AU2012304909B2 (en) * | 2011-06-10 | 2017-06-08 | Icon Bioscience, Inc. | Sustained release formulations for delivery of proteins to the eye and methods of preparing same |
US20130035338A1 (en) * | 2011-08-05 | 2013-02-07 | Gordon Tang | Eyelid treatment |
US9522951B2 (en) | 2011-10-31 | 2016-12-20 | Bristol-Myers Squibb Company | Fibronectin binding domains with reduced immunogenicity |
JP2015514107A (ja) * | 2012-04-05 | 2015-05-18 | ユニバーシティ オブ セントラル フロリダ リサーチ ファウンデーション,インコーポレイテッド | 角膜増殖のための組成物及び方法 |
KR101312926B1 (ko) * | 2012-05-14 | 2013-10-01 | 크루셜텍 (주) | 로봇청소기의 감지장치 및 감지방법 |
JP6294885B2 (ja) | 2012-08-30 | 2018-03-14 | エーティーアールピー ソリューションズ インコーポレイテッドATRP Solutions,Inc. | 星形高分子、星形高分子組成物および星形高分子の製造方法 |
CN104768969B (zh) | 2012-09-13 | 2021-04-16 | 百时美施贵宝公司 | 结合至肌生成抑制素的基于纤连蛋白的支架结构域蛋白 |
BR112015006087A2 (pt) * | 2012-09-20 | 2017-07-04 | Akina Inc | microcápsulas biodegradáveis contendo material de enchimento |
ES2709351T3 (es) | 2012-09-27 | 2019-04-16 | Allergan Inc | Sistemas de administración de fármacos biodegradables para la liberación sostenida de proteínas |
AU2014209141B2 (en) | 2013-01-24 | 2018-05-10 | Palvella Therapeutics, Inc. | Compositions for transdermal delivery of mTOR inhibitors |
US20150361159A1 (en) | 2013-02-01 | 2015-12-17 | Bristol-Myers Squibb Company | Fibronectin based scaffold proteins |
CN105263978B (zh) | 2013-02-04 | 2018-04-17 | Atrp解决方案公司 | 耐盐星形大分子 |
EP3406629B1 (fr) | 2013-02-06 | 2020-06-24 | Bristol-Myers Squibb Company | Protéines du domaine de la fibronectine de type iii à solubilité améliorée |
US10065987B2 (en) | 2013-02-12 | 2018-09-04 | Bristol-Myers Squibb Company | High pH protein refolding methods |
US10517759B2 (en) | 2013-03-15 | 2019-12-31 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
KR20160004288A (ko) | 2013-05-06 | 2016-01-12 | 가오슝 창 궁 메모리얼 하스피털 | 약학적 조성물 및 이의 용도 |
WO2015023675A2 (fr) | 2013-08-12 | 2015-02-19 | Pharmaceutical Manufacturing Research Services, Inc. | Comprimé extrudé anti-abus à libération immédiate |
KR102307281B1 (ko) | 2013-10-31 | 2021-09-29 | 알레간 인코포레이티드 | 프로스타마이드-함유 안구내 삽입물 및 그것의 사용 방법 |
WO2015095391A1 (fr) | 2013-12-17 | 2015-06-25 | Pharmaceutical Manufacturing Research Services, Inc. | Comprimé extrudé anti-abus à libération prolongée |
US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
GB201404139D0 (en) | 2014-03-10 | 2014-04-23 | Rb Pharmaceuticals Ltd | Sustained release buprenorphine solution formulations |
JP6655610B2 (ja) | 2014-05-29 | 2020-02-26 | グローコス コーポレーション | 制御された薬物送達機能を備えるインプラント及びそれを使用する方法 |
MX2017000076A (es) | 2014-07-03 | 2017-05-01 | Atrp Solutions Inc | Macromoleculas estrellas compatibles con tensoactivos. |
WO2016010771A1 (fr) | 2014-07-17 | 2016-01-21 | Pharmaceutical Manufacturing Research Services, Inc. | Forme posologique remplie de liquide anti-abus à libération immédiate |
JP2017531026A (ja) | 2014-10-20 | 2017-10-19 | ファーマシューティカル マニュファクチュアリング リサーチ サービシズ,インコーポレーテッド | 徐放性乱用抑止性液体充填剤形 |
CA3015557C (fr) | 2014-11-07 | 2019-07-16 | Indivior Uk Limited | L'utilisation de formules de burpenorphine a liberation constante pour le traitement de la douleur ou des troubles de consommation d'opioide |
WO2016141182A1 (fr) | 2015-03-03 | 2016-09-09 | Yee Richard W | Compositions et méthodes de traitement de maladies oculaires |
JP2016175900A (ja) * | 2015-03-18 | 2016-10-06 | 参天製薬株式会社 | 徐放性医薬組成物 |
US11213480B1 (en) | 2015-08-06 | 2022-01-04 | Hikma Pharmaceuticals International Limited | Phenylephrine hydrochloride ready-to-use solution |
WO2017040853A1 (fr) | 2015-09-02 | 2017-03-09 | Glaukos Corporation | Implants d'administration de médicament présentant capacité d'administration bidirectionnelle |
US11564833B2 (en) | 2015-09-25 | 2023-01-31 | Glaukos Corporation | Punctal implants with controlled drug delivery features and methods of using same |
US10761087B2 (en) * | 2015-12-17 | 2020-09-01 | Link Genomics, Inc. | Choroidal neovascularization suppressor or drusen formation suppressor, and method for assessing or screening for same |
JP7003110B2 (ja) | 2016-04-20 | 2022-01-20 | ドーズ メディカル コーポレーション | 生体吸収性眼球薬物送達デバイス |
WO2018129364A1 (fr) | 2017-01-06 | 2018-07-12 | Palvella Therapeutics Llc | Compositions anhydres d'inhibiteurs de mtor et méthodes d'utilisation |
WO2018151849A1 (fr) | 2017-02-17 | 2018-08-23 | Privo Technologies, Inc. | Dispositif et méthode d'administration d'agents thérapeutiques multicouche à base de particules |
US10646484B2 (en) | 2017-06-16 | 2020-05-12 | Indivior Uk Limited | Methods to treat opioid use disorder |
BR102017016440A2 (pt) | 2017-07-31 | 2019-03-19 | Universidade Federal Do Rio Grande Do Sul | Composição para terapia gênica do sistema nervoso central, processo de obtenção e uso da mesma |
CN108379289A (zh) * | 2018-04-03 | 2018-08-10 | 高永鹏 | 一种用于牛、羊眼部疾病的喷剂 |
WO2020010073A1 (fr) | 2018-07-02 | 2020-01-09 | Palvella Therapeutics, Inc. | Compositions anhydres d'inhibiteurs de mtor et méthodes d'utilisation |
US11679028B2 (en) * | 2019-03-06 | 2023-06-20 | Novartis Ag | Multi-dose ocular fluid delivery system |
CN115243722A (zh) * | 2020-01-03 | 2022-10-25 | 派沃技术公司 | 通过直接注射靶细胞群进行治疗的系统和药物组合物 |
CN116528851A (zh) * | 2020-06-26 | 2023-08-01 | 普渡研究基金会 | 用于长期眼部递送的灰黄霉素的药物制剂 |
FI20215186A1 (en) * | 2021-02-19 | 2022-08-20 | Rebio Tech Oy | Compositions for ophthalmic treatment |
US11779553B1 (en) | 2022-11-28 | 2023-10-10 | Atif B. D. Collins | Methods and devices for treatment of eyelid ptosis |
Family Cites Families (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3416530A (en) * | 1966-03-02 | 1968-12-17 | Richard A. Ness | Eyeball medication dispensing tablet |
US4179497A (en) * | 1973-12-17 | 1979-12-18 | Merck & Co., Inc. | Solid state ophthalmic medication |
US3993749A (en) * | 1974-04-12 | 1976-11-23 | Ayerst Mckenna And Harrison Ltd. | Rapamycin and process of preparation |
US3963025A (en) * | 1974-09-16 | 1976-06-15 | Alza Corporation | Ocular drug delivery device |
US4053580A (en) * | 1975-01-01 | 1977-10-11 | G. D. Searle & Co. | Microsealed pharmaceutical delivery device |
US4164559A (en) * | 1977-09-21 | 1979-08-14 | Cornell Research Foundation, Inc. | Collagen drug delivery device |
US4885171A (en) * | 1978-11-03 | 1989-12-05 | American Home Products Corporation | Use of rapamycin in treatment of certain tumors |
US5206018A (en) * | 1978-11-03 | 1993-04-27 | Ayerst, Mckenna & Harrison, Inc. | Use of rapamycin in treatment of tumors |
US4249531A (en) * | 1979-07-05 | 1981-02-10 | Alza Corporation | Bioerodible system for delivering drug manufactured from poly(carboxylic acid) |
US4316885A (en) * | 1980-08-25 | 1982-02-23 | Ayerst, Mckenna And Harrison, Inc. | Acyl derivatives of rapamycin |
US4346709A (en) * | 1980-11-10 | 1982-08-31 | Alza Corporation | Drug delivery devices comprising erodible polymer and erosion rate modifier |
US4401653A (en) * | 1981-03-09 | 1983-08-30 | Ayerst, Mckenna & Harrison Inc. | Combination of rapamycin and picibanil for the treatment of tumors |
JPS60100516A (ja) * | 1983-11-04 | 1985-06-04 | Takeda Chem Ind Ltd | 徐放型マイクロカプセルの製造法 |
US4612302A (en) * | 1983-11-14 | 1986-09-16 | Brigham And Women's Hospital | Clinical use of somatostatin analogues |
US4684620A (en) * | 1984-09-04 | 1987-08-04 | Gibson-Stephens Neuropharmaceuticals, Inc. | Cyclic polypeptides having mu-receptor specificity |
DE3678308D1 (de) * | 1985-02-07 | 1991-05-02 | Takeda Chemical Industries Ltd | Verfahren zur herstellung von mikrokapseln. |
US4853371A (en) * | 1986-06-17 | 1989-08-01 | The Administrators Of The Tulane Educational Fund | Therapeutic somatostatin analogs |
US5632727A (en) * | 1988-10-03 | 1997-05-27 | Atrix Laboratories, Inc. | Biodegradable film dressing and method for its formation |
US4938763B1 (en) * | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
US5182258A (en) * | 1989-03-20 | 1993-01-26 | Orbon Corporation | Systemic delivery of polypeptides through the eye |
US5100899A (en) * | 1989-06-06 | 1992-03-31 | Roy Calne | Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof |
US5487897A (en) * | 1989-07-24 | 1996-01-30 | Atrix Laboratories, Inc. | Biodegradable implant precursor |
US5324519A (en) * | 1989-07-24 | 1994-06-28 | Atrix Laboratories, Inc. | Biodegradable polymer composition |
MY107937A (en) * | 1990-02-13 | 1996-06-29 | Takeda Chemical Industries Ltd | Prolonged release microcapsules. |
US5130307A (en) * | 1990-09-28 | 1992-07-14 | American Home Products Corporation | Aminoesters of rapamycin |
US5233036A (en) * | 1990-10-16 | 1993-08-03 | American Home Products Corporation | Rapamycin alkoxyesters |
US5080899A (en) * | 1991-02-22 | 1992-01-14 | American Home Products Corporation | Method of treating pulmonary inflammation |
US5078999A (en) * | 1991-02-22 | 1992-01-07 | American Home Products Corporation | Method of treating systemic lupus erythematosus |
US5120842A (en) * | 1991-04-01 | 1992-06-09 | American Home Products Corporation | Silyl ethers of rapamycin |
US5100883A (en) * | 1991-04-08 | 1992-03-31 | American Home Products Corporation | Fluorinated esters of rapamycin |
US5138051A (en) * | 1991-08-07 | 1992-08-11 | American Home Products Corporation | Rapamycin analogs as immunosuppressants and antifungals |
US5102876A (en) * | 1991-05-07 | 1992-04-07 | American Home Products Corporation | Reduction products of rapamycin |
US5118677A (en) * | 1991-05-20 | 1992-06-02 | American Home Products Corporation | Amide esters of rapamycin |
ZA924953B (en) * | 1991-07-25 | 1993-04-28 | Univ Louisville Res Found | Method of treating ocular inflammation |
DE69220317T2 (de) * | 1991-10-01 | 1997-10-16 | Takeda Chemical Industries Ltd | Mikropartikeln-Zusammenfassung zur verlängerten Freigabe und Herstellung derselbe |
AU2605592A (en) * | 1991-10-15 | 1993-04-22 | Atrix Laboratories, Inc. | Polymeric compositions useful as controlled release implants |
US5151413A (en) * | 1991-11-06 | 1992-09-29 | American Home Products Corporation | Rapamycin acetals as immunosuppressant and antifungal agents |
US5164399A (en) * | 1991-11-18 | 1992-11-17 | American Home Products Corporation | Rapamycin pyrazoles |
US5221740A (en) * | 1992-01-16 | 1993-06-22 | American Home Products Corporation | Oxepane isomers of rapamycin useful as immunosuppressive agents |
US5177203A (en) * | 1992-03-05 | 1993-01-05 | American Home Products Corporation | Rapamycin 42-sulfonates and 42-(N-carboalkoxy) sulfamates useful as immunosuppressive agents |
EP0560014A1 (fr) * | 1992-03-12 | 1993-09-15 | Atrix Laboratories, Inc. | Pansement sous forme de film biodégradable et méthode pour sa fabrication |
US5288711A (en) * | 1992-04-28 | 1994-02-22 | American Home Products Corporation | Method of treating hyperproliferative vascular disease |
JP3277342B2 (ja) * | 1992-09-02 | 2002-04-22 | 武田薬品工業株式会社 | 徐放性マイクロカプセルの製造法 |
GB9221220D0 (en) * | 1992-10-09 | 1992-11-25 | Sandoz Ag | Organic componds |
US5434260A (en) * | 1992-10-13 | 1995-07-18 | American Home Products Corporation | Carbamates of rapamycin |
US5242910A (en) * | 1992-10-13 | 1993-09-07 | The Procter & Gamble Company | Sustained release compositions for treating periodontal disease |
MY113268A (en) * | 1992-12-29 | 2002-01-31 | Insite Vision Incorporated | Plasticized bioerodible controlled delivery system |
US6221958B1 (en) * | 1993-01-06 | 2001-04-24 | Societe De Conseils De Recherches Et D'applications Scientifiques, Sas | Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
US5863985A (en) * | 1995-06-29 | 1999-01-26 | Kinerton Limited | Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
US5504091A (en) * | 1993-04-23 | 1996-04-02 | American Home Products Corporation | Biotin esters of rapamycin |
US6447196B1 (en) * | 1993-05-12 | 2002-09-10 | George A. Arkwright | Adhesive fastener assembly |
US5373014A (en) * | 1993-10-08 | 1994-12-13 | American Home Products Corporation | Rapamycin oximes |
US5681873A (en) * | 1993-10-14 | 1997-10-28 | Atrix Laboratories, Inc. | Biodegradable polymeric composition |
DE69524398T2 (de) * | 1994-04-08 | 2002-07-18 | Atrix Lab Inc | Flüssige mittel zur wirkstoffabgabe |
US5362718A (en) * | 1994-04-18 | 1994-11-08 | American Home Products Corporation | Rapamycin hydroxyesters |
US6447796B1 (en) * | 1994-05-16 | 2002-09-10 | The United States Of America As Represented By The Secretary Of The Army | Sustained release hydrophobic bioactive PLGA microspheres |
US5463048A (en) * | 1994-06-14 | 1995-10-31 | American Home Products Corporation | Rapamycin amidino carbamates |
US5561138A (en) * | 1994-12-13 | 1996-10-01 | American Home Products Corporation | Method of treating anemia |
US5718922A (en) * | 1995-05-31 | 1998-02-17 | Schepens Eye Research Institute, Inc. | Intravitreal microsphere drug delivery and method of preparation |
CA2222287A1 (fr) * | 1995-06-02 | 1996-12-05 | Hermanus Marcellinus Maria Klein Koerkamp | Dispositif thermo-optique en cascade |
US5736152A (en) * | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
US5780462A (en) * | 1995-12-27 | 1998-07-14 | American Home Products Corporation | Water soluble rapamycin esters |
ATE279185T1 (de) * | 1995-12-28 | 2004-10-15 | Mitsubishi Pharma Corp | 2-amino-2-(2-(4-octylphenyl)ethyl)propan-1,3-di l enthaltendes arzneimittel zur topischen anwendung zur behandlung von erkrankungen die durch eine störung des immunsystems hervorgerufen werden |
US5922730A (en) * | 1996-09-09 | 1999-07-13 | American Home Products Corporation | Alkylated rapamycin derivatives |
DE69730093T2 (de) * | 1996-10-31 | 2006-07-20 | Takeda Pharmaceutical Co. Ltd. | Zubereitung mit verzögerter Freisetzung |
US6342250B1 (en) * | 1997-09-25 | 2002-01-29 | Gel-Del Technologies, Inc. | Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices |
FR2770694B1 (fr) * | 1997-11-03 | 1999-12-17 | Commissariat Energie Atomique | Dispositif de laser a gaz et a moyens de purification de gaz integres |
US6261583B1 (en) * | 1998-07-28 | 2001-07-17 | Atrix Laboratories, Inc. | Moldable solid delivery system |
US6143314A (en) * | 1998-10-28 | 2000-11-07 | Atrix Laboratories, Inc. | Controlled release liquid delivery compositions with low initial drug burst |
US6565874B1 (en) * | 1998-10-28 | 2003-05-20 | Atrix Laboratories | Polymeric delivery formulations of leuprolide with improved efficacy |
US6355657B1 (en) * | 1998-12-30 | 2002-03-12 | Atrix Laboratories, Inc. | System for percutaneous delivery of opioid analgesics |
US6264971B1 (en) * | 1999-11-04 | 2001-07-24 | Btg International Limited | Ocular insert |
US6461631B1 (en) * | 1999-11-16 | 2002-10-08 | Atrix Laboratories, Inc. | Biodegradable polymer composition |
ES2283394T3 (es) * | 2000-01-11 | 2007-11-01 | Bertex Pharma Gmbh | Kit para implantacion que contiene una fase de soporte y un disolvente. |
US20040170665A1 (en) * | 2000-06-02 | 2004-09-02 | Allergan, Inc. | Intravitreal botulinum toxin implant |
US6399625B1 (en) * | 2000-09-27 | 2002-06-04 | Wyeth | 1-oxorapamycins |
CA2455311A1 (fr) * | 2001-08-22 | 2003-03-06 | Wyeth | Dialdehydes rapamycine |
CA2455308A1 (fr) * | 2001-08-22 | 2003-03-06 | Wyeth | 29-enols de la rapamycine |
WO2004011054A2 (fr) * | 2002-07-31 | 2004-02-05 | Alza Corporation | Compositions de depot polymere multimode injectables et leurs utilisations |
PT1539157E (pt) * | 2002-09-18 | 2013-10-04 | Univ Pennsylvania | Rapamicina para utilização na inibição ou prevenção de neovascularização coroidal |
CA2518791A1 (fr) * | 2003-03-11 | 2004-09-23 | Qlt Usa Inc. | Preparations d'agents anti-cancereux dependant du programme cellulaire |
US7585517B2 (en) * | 2003-09-18 | 2009-09-08 | Macusight, Inc. | Transscleral delivery |
-
2005
- 2005-10-04 KR KR1020077010077A patent/KR20070083941A/ko not_active Application Discontinuation
- 2005-10-04 MX MX2007003789A patent/MX2007003789A/es unknown
- 2005-10-04 CA CA002582374A patent/CA2582374A1/fr not_active Abandoned
- 2005-10-04 AU AU2005294382A patent/AU2005294382A1/en not_active Abandoned
- 2005-10-04 BR BRPI0516308-0A patent/BRPI0516308A2/pt not_active IP Right Cessation
- 2005-10-04 JP JP2007534913A patent/JP2008520547A/ja active Pending
- 2005-10-04 US US11/244,438 patent/US20060210604A1/en not_active Abandoned
- 2005-10-04 EP EP05802028A patent/EP1804751A2/fr not_active Withdrawn
- 2005-10-04 WO PCT/US2005/035865 patent/WO2006041942A2/fr active Application Filing
-
2007
- 2007-05-04 NO NO20072318A patent/NO20072318L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MX2007003789A (es) | 2007-07-20 |
KR20070083941A (ko) | 2007-08-24 |
US20060210604A1 (en) | 2006-09-21 |
AU2005294382A1 (en) | 2006-04-20 |
WO2006041942A3 (fr) | 2009-04-23 |
JP2008520547A (ja) | 2008-06-19 |
WO2006041942A2 (fr) | 2006-04-20 |
EP1804751A2 (fr) | 2007-07-11 |
CA2582374A1 (fr) | 2006-04-20 |
BRPI0516308A2 (pt) | 2010-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20072318L (no) | Okular levering av polymere leveringsformuleringer | |
Nyitray et al. | Polycaprolactone thin-film micro-and nanoporous cell-encapsulation devices | |
CN103463675B (zh) | 一种抗菌抗肿瘤骨科植入材料及其制备方法 | |
RU2606662C2 (ru) | Устройства и способы для расширения отверстия придаточной пазухи носа и для лечения синусита | |
JP2018504167A5 (fr) | ||
CN108136070A (zh) | 创伤后骨关节炎的预防性治疗 | |
BRPI0822625B8 (pt) | dispositivo espaçador modular para o tratamento de infecções por próteses | |
JP2013512968A5 (fr) | ||
NO20084471L (no) | Nasolakrimalt dreneringssystemimplantater for legemiddelterapi | |
PJ et al. | Biomedical applications of polymers—An overview | |
CN105232532A (zh) | 维生素c和维生素k的组合及其用途 | |
RU2016110605A (ru) | Способ получения инъекционного гидрогеля на основе гиалуроновой кислоты, содержащего лидокаин и щелочной агент, стерилизованного теплом | |
ES2214988T3 (es) | Hidrogel de poliacrilamida y su uso como una endoprotesis. | |
Alshammari et al. | An update on microneedle in insulin delivery: quality attributes, clinical status and challenges for clinical translation | |
JP6533235B2 (ja) | 生物医学的応用における使用のためのシクロデキストリンを組み入れたコラーゲンマトリクスを含む組成物 | |
Gopan et al. | The use of cellulose, chitosan and hyaluronic acid in transdermal therapeutic management of obesity: A review | |
Chakraborty et al. | Engineering multifunctional adhesive hydrogel patches for biomedical applications | |
Budama-Kilinc et al. | Hydrogels in regenerative medicine | |
WO2008088536A8 (fr) | Libération différentielle de médicament à partir d'un dispositif médical | |
ATE267843T1 (de) | Verfahren zur herstellung von selbstvernetzten hyaluronsäuren und deren derivaten mittels superkritischer anti-lösungsmittel | |
WO2010039970A3 (fr) | Application d'une contrainte de cisaillement pour le traitement d'une maladie | |
CN106177970B (zh) | 罗哌卡因注射用制剂及其制备方法和应用 | |
Zhou et al. | Nanomaterials in the sports rehabilitation of basketball players after anterior cruciate ligament reconstruction | |
US20210085467A1 (en) | Selective targeted release | |
Tören | Regenerative Medicine and Tissue Engineering: Advancements and Challenges in Cell-Based Therapies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |